Qualigen Therapeutics Inc. (AIXC)
NASDAQ · Healthcare
Qualigen Therapeutics Inc. annual/quarterly total liabilities history from 2020 to 2022. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Qualigen Therapeutics Inc. total liabilities for the quarter ending December 31, 2022 were 10.3M, a 64.52% increase year-over-year.
- Qualigen Therapeutics Inc. total liabilities for 2022 were 10.3M, a 64.52% increase from 2021.
- Qualigen Therapeutics Inc. total liabilities for 2021 were 6.3M, a 42.11% decrease from 2020.
- Qualigen Therapeutics Inc. total liabilities for 2020 were 10.8M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Qualigen Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2022 | $10 |
| 2021 | $6 |
| 2020 | $11 |
| Qualigen Therapeutics Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2022-12-31 | $10 |
| 2021-12-31 | $6 |
| 2020-12-31 | $11 |
| 2020-03-31 | $6 |
Qualigen Therapeutics Inc. Total Liabilities — FAQ
Qualigen Therapeutics Inc. (AIXC) total liabilities over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AIXC's total liabilities history?
The chart and table above show Qualigen Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.